Illumina Sued Again Over Roche Bid | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – A class action lawsuit has been filed against Illumina alleging a breach of fiduciary duties by its board in connection with Roche's $5.7 billion hostile bid for the company.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: weighting scheme increases GWAS power, and more.

Marc Tessier-Lavigne is to be the next president of Stanford University.

Walgreens has given Theranos 30 days to fix its lab issues, the Wall Street Journal reports.

Journals and research funding agencies pledge to enable the sharing of Zika virus research.